US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist

3.035
+0.095+3.21%

Close Aug 7 16:00 ET

25.21MMarket Cap-1233P/E (TTM)

Lisata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

14.26%-7.03M

5.38%-20.03M

37.09%-4.07M

10.38%-3.58M

17.34%-4.18M

-45.27%-8.2M

4.83%-21.17M

-40.49%-6.47M

20.66%-4M

-9.40%-5.06M

Net income from continuing operations

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

-439.67%-37.38M

-16.61%-6.63M

Operating gains losses

3,233.33%100K

--3K

--0

--3K

----

Depreciation and amortization

-4.17%46K

173.91%189K

0.00%47K

487.50%47K

571.43%47K

585.71%48K

25.45%69K

487.50%47K

-42.86%8K

-58.82%7K

Other non cash items

----

--30.39M

--0

----

Change In working capital

19.24%-2.07M

44.40%-462K

215.65%1.03M

-17.63%1.61M

-165.67%-528K

4.82%-2.57M

-228.44%-831K

-172.37%-888K

529.35%1.95M

2,014.29%804K

-Change in prepaid assets

47.22%-872K

2.49%-824K

41.65%-510K

9.57%847K

118.22%491K

-70.49%-1.65M

-86.53%-845K

-217.16%-874K

2,242.42%773K

-57.63%225K

-Change in payables and accrued expense

-14.77%-1.24M

139.46%88K

2,008.22%1.39M

-33.18%747K

-287.07%-969K

39.36%-1.08M

-117.84%-223K

-108.27%-73K

485.34%1.12M

178.72%518K

-Change in other current assets

-75.45%41K

15.61%274K

144.07%144K

-78.33%13K

-181.97%-50K

192.98%167K

258.00%237K

114.68%59K

-30.23%60K

-28.24%61K

Cash from discontinued investing activities

Operating cash flow

14.26%-7.03M

5.38%-20.03M

37.09%-4.07M

10.38%-3.58M

17.34%-4.18M

-45.27%-8.2M

4.83%-21.17M

-40.49%-6.47M

20.66%-4M

-9.40%-5.06M

Investing cash flow

Cash flow from continuing investing activities

50.06%6.44M

-65.06%10.1M

-180.41%-5.71M

441.88%12.25M

-102.83%-725K

170.43%4.29M

152.67%28.91M

-56.82%7.11M

-54.23%2.26M

328.79%25.63M

Net PPE purchase and sale

----

--0

----

-375.00%-285K

---26K

---24K

----

Net business purchase and sale

---100K

----

--0

----

Net investment purchase and sale

52.39%6.54M

-68.93%10.1M

-180.12%-5.71M

378.77%12.25M

-102.02%-725K

170.43%4.29M

159.30%32.52M

-56.67%7.13M

-188.97%-4.4M

421.87%35.87M

Net other investing changes

----

---3.32M

--0

----

Cash from discontinued investing activities

Investing cash flow

50.06%6.44M

-65.06%10.1M

-180.41%-5.71M

441.88%12.25M

-102.83%-725K

170.43%4.29M

152.67%28.91M

-56.82%7.11M

-54.23%2.26M

328.79%25.63M

Financing cash flow

Cash flow from continuing financing activities

-67.06%-142K

271.88%385K

71.43%24K

93.94%-6K

1,458.62%452K

49.40%-85K

-100.26%-224K

-33.33%14K

-54.69%-99K

31.82%29K

Net common stock issuance

----

646.51%321K

71.43%24K

--0

----

-99.95%43K

-33.33%14K

--0

----

Proceeds from stock option exercised by employees

----

--155K

--0

----

--0

----

Net other financing activities

-67.06%-142K

65.92%-91K

--0

93.94%-6K

--0

49.40%-85K

-7.66%-267K

--0

-54.69%-99K

--0

Cash from discontinued financing activities

Financing cash flow

-67.06%-142K

271.88%385K

71.43%24K

93.94%-6K

1,458.62%452K

49.40%-85K

-100.26%-224K

-33.33%14K

-54.69%-99K

31.82%29K

Net cash flow

Beginning cash position

-29.74%22.59M

30.46%32.15M

3.02%32.43M

-28.96%23.69M

120.88%28.16M

30.46%32.15M

49.27%24.65M

146.46%31.48M

157.81%33.35M

-55.65%12.75M

Current changes in cash

81.64%-733K

-226.98%-9.55M

-1,596.78%-9.76M

571.84%8.66M

-121.63%-4.46M

66.45%-3.99M

-7.60%7.52M

-94.51%652K

-1,026.38%-1.84M

230.31%20.6M

Effect of exchange rate changes

-685.71%-55K

-60.00%-16K

-416.67%-76K

320.59%75K

---8K

---7K

---10K

--24K

---34K

--0

End cash Position

-22.55%21.81M

-29.74%22.59M

3.02%32.43M

-28.96%23.69M

120.88%28.16M

30.46%32.15M

146.46%31.48M

157.81%33.35M

Free cash flow

14.26%-7.03M

6.63%-20.03M

37.34%-4.07M

10.91%-3.58M

21.01%-4.18M

-45.27%-8.2M

3.81%-21.46M

-41.05%-6.49M

20.18%-4.02M

-13.01%-5.3M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	14.26%-7.03M	5.38%-20.03M	37.09%-4.07M	10.38%-3.58M	17.34%-4.18M	-45.27%-8.2M	4.83%-21.17M	-40.49%-6.47M	20.66%-4M	-9.40%-5.06M
Net income from continuing operations	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M	-439.67%-37.38M	-16.61%-6.63M
Operating gains losses	3,233.33%100K	--3K	--0	--0	--0	--3K	----	----	----	----
Depreciation and amortization	-4.17%46K	173.91%189K	0.00%47K	487.50%47K	571.43%47K	585.71%48K	25.45%69K	487.50%47K	-42.86%8K	-58.82%7K
Other non cash items	----	----	----	----	----	----	--30.39M	--0	----	----
Change In working capital	19.24%-2.07M	44.40%-462K	215.65%1.03M	-17.63%1.61M	-165.67%-528K	4.82%-2.57M	-228.44%-831K	-172.37%-888K	529.35%1.95M	2,014.29%804K
-Change in prepaid assets	47.22%-872K	2.49%-824K	41.65%-510K	9.57%847K	118.22%491K	-70.49%-1.65M	-86.53%-845K	-217.16%-874K	2,242.42%773K	-57.63%225K
-Change in payables and accrued expense	-14.77%-1.24M	139.46%88K	2,008.22%1.39M	-33.18%747K	-287.07%-969K	39.36%-1.08M	-117.84%-223K	-108.27%-73K	485.34%1.12M	178.72%518K
-Change in other current assets	-75.45%41K	15.61%274K	144.07%144K	-78.33%13K	-181.97%-50K	192.98%167K	258.00%237K	114.68%59K	-30.23%60K	-28.24%61K
Cash from discontinued investing activities
Operating cash flow	14.26%-7.03M	5.38%-20.03M	37.09%-4.07M	10.38%-3.58M	17.34%-4.18M	-45.27%-8.2M	4.83%-21.17M	-40.49%-6.47M	20.66%-4M	-9.40%-5.06M
Investing cash flow
Cash flow from continuing investing activities	50.06%6.44M	-65.06%10.1M	-180.41%-5.71M	441.88%12.25M	-102.83%-725K	170.43%4.29M	152.67%28.91M	-56.82%7.11M	-54.23%2.26M	328.79%25.63M
Net PPE purchase and sale	----	--0	--0	--0	----	----	-375.00%-285K	---26K	---24K	----
Net business purchase and sale	---100K	----	----	----	--0	--0	----	----	----	----
Net investment purchase and sale	52.39%6.54M	-68.93%10.1M	-180.12%-5.71M	378.77%12.25M	-102.02%-725K	170.43%4.29M	159.30%32.52M	-56.67%7.13M	-188.97%-4.4M	421.87%35.87M
Net other investing changes	----	----	----	----	----	----	---3.32M	--0	----	----
Cash from discontinued investing activities
Investing cash flow	50.06%6.44M	-65.06%10.1M	-180.41%-5.71M	441.88%12.25M	-102.83%-725K	170.43%4.29M	152.67%28.91M	-56.82%7.11M	-54.23%2.26M	328.79%25.63M
Financing cash flow
Cash flow from continuing financing activities	-67.06%-142K	271.88%385K	71.43%24K	93.94%-6K	1,458.62%452K	49.40%-85K	-100.26%-224K	-33.33%14K	-54.69%-99K	31.82%29K
Net common stock issuance	----	646.51%321K	71.43%24K	--0	----	----	-99.95%43K	-33.33%14K	--0	----
Proceeds from stock option exercised by employees	----	--155K	--0	--0	----	----	--0	--0	--0	----
Net other financing activities	-67.06%-142K	65.92%-91K	--0	93.94%-6K	--0	49.40%-85K	-7.66%-267K	--0	-54.69%-99K	--0
Cash from discontinued financing activities
Financing cash flow	-67.06%-142K	271.88%385K	71.43%24K	93.94%-6K	1,458.62%452K	49.40%-85K	-100.26%-224K	-33.33%14K	-54.69%-99K	31.82%29K
Net cash flow
Beginning cash position	-29.74%22.59M	30.46%32.15M	3.02%32.43M	-28.96%23.69M	120.88%28.16M	30.46%32.15M	49.27%24.65M	146.46%31.48M	157.81%33.35M	-55.65%12.75M
Current changes in cash	81.64%-733K	-226.98%-9.55M	-1,596.78%-9.76M	571.84%8.66M	-121.63%-4.46M	66.45%-3.99M	-7.60%7.52M	-94.51%652K	-1,026.38%-1.84M	230.31%20.6M
Effect of exchange rate changes	-685.71%-55K	-60.00%-16K	-416.67%-76K	320.59%75K	---8K	---7K	---10K	--24K	---34K	--0
End cash Position	-22.55%21.81M	-29.74%22.59M	-29.74%22.59M	3.02%32.43M	-28.96%23.69M	120.88%28.16M	30.46%32.15M	30.46%32.15M	146.46%31.48M	157.81%33.35M
Free cash flow	14.26%-7.03M	6.63%-20.03M	37.34%-4.07M	10.91%-3.58M	21.01%-4.18M	-45.27%-8.2M	3.81%-21.46M	-41.05%-6.49M	20.18%-4.02M	-13.01%-5.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall